Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Jul 04 2024
Business
Jul 4 2024
3 min read

Press Release Jul 04 2024

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 04, 2024, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivosidenib Tablets 250 mg".

View Attachment